TSX Pre-Market: TMD.TO Titan Medical C$1.13, 117k shrs Mar 2026: liquidity watch
Pre-market update on TMD.TO stock at C$1.13 with heavy volume and liquidity risks
Pre-market update on TMD.TO stock at C$1.13 with heavy volume and liquidity risks
WCM Europe administration and HPL Prototypes strain the UK automotive supplier base. Buyer sought, timeline risks rise. Clear investor and procurement steps to reduce disruption.
Pre-market MOBX stock jumps on U.S. Navy Tomahawk order; heavy volume and Meyka AI grade B review
Macquarie maintains Neutral on GitLab; our analysis covers the GTLB analyst rating, price impacts, and Meyka AI grade B+
GLJ Research starts NVT initial Buy. NVT analyst rating update, implications and Meyka grade A
Nippon Life OpenAI lawsuit puts AI compliance risk in focus for Japan investors. We review Microsoft stock today, legal exposure, and practical controls for regulated users.
6614.T stock jumps 14.53% to JPY 883.00 on 06 Mar 2026; Meyka AI monthly forecast JPY 959.55
8422.HK stock slides 16.45% to HK$0.127 on 06 Mar 2026; technical support at HK$0.08 and model-led target HK$0.16
Intraday update on MDQK.HM stock: €7.50, +200.00% on 06 Mar 2026 with tight volume and valuation context
Zelensky threatens Orban as Hungary blocks a €90B EU credit to Ukraine, raising risks for EU unity, Druzhba pipeline transit, and bank compliance. Swiss investors’ takeaways inside.